GT200300017A - Sistema de suministro osmotico - Google Patents

Sistema de suministro osmotico

Info

Publication number
GT200300017A
GT200300017A GT200300017A GT200300017A GT200300017A GT 200300017 A GT200300017 A GT 200300017A GT 200300017 A GT200300017 A GT 200300017A GT 200300017 A GT200300017 A GT 200300017A GT 200300017 A GT200300017 A GT 200300017A
Authority
GT
Guatemala
Prior art keywords
supply system
osmotic
coat
compressed
osmotic supply
Prior art date
Application number
GT200300017A
Other languages
English (en)
Inventor
Anne Martine Billotte
Rebecca Lyn Carrier
Michael Bruce Fergione
Lee Anthony Miller
Michael Christopher Roy
Sheri Lynn Shamblin
Kenneth Craig Waterman
Bruce Clinton Macdonald
Dwayne Thomas Friesen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200300017A publication Critical patent/GT200300017A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EN LA PRESENTE INVENCION SE DESCRIBE UN COMPRIMIDO FARMACEUTICO OSMOTICO QUE COMPRENDE UN NUCLEO COMPRIMIDO DE CAPA SENCILLA RODEADO POR UNA CAPA PERMEABLE AL AGUA QUE TIENE UN PASO. EL NUCLEO DE CAPA SENCILLA CONTIENE I) UN FARMACO NO MADURADOR II) APROXIMADAMENTE DE 2.0% A 20% EN PESO DE UNA HIDROXIETILCELULOSA III) UN AGENTE OSMOTICO.
GT200300017A 2002-02-01 2003-01-29 Sistema de suministro osmotico GT200300017A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35315102P 2002-02-01 2002-02-01

Publications (1)

Publication Number Publication Date
GT200300017A true GT200300017A (es) 2003-09-22

Family

ID=27663182

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200300017A GT200300017A (es) 2002-02-01 2003-01-29 Sistema de suministro osmotico

Country Status (23)

Country Link
US (1) US20030175346A1 (es)
EP (1) EP1469826B1 (es)
JP (1) JP2005518418A (es)
KR (1) KR20040083492A (es)
CN (1) CN1625388A (es)
AR (1) AR038373A1 (es)
AT (1) ATE345776T1 (es)
BR (1) BR0307320A (es)
CA (1) CA2474425A1 (es)
DE (1) DE60309832T2 (es)
ES (1) ES2277632T3 (es)
GT (1) GT200300017A (es)
MX (1) MXPA04007437A (es)
NO (1) NO20043646L (es)
NZ (1) NZ533986A (es)
PA (1) PA8565201A1 (es)
PE (1) PE20030801A1 (es)
PL (1) PL372172A1 (es)
RU (1) RU2004123623A (es)
TW (1) TW200302748A (es)
UY (1) UY27644A1 (es)
WO (1) WO2003063823A2 (es)
ZA (1) ZA200405406B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
US7829507B2 (en) * 2003-09-17 2010-11-09 Halliburton Energy Services Inc. Subterranean treatment fluids comprising a degradable bridging agent and methods of treating subterranean formations
WO2006057912A2 (en) * 2004-11-24 2006-06-01 Teva Pharmaceutical Industries, Ltd. Rasagiline orally disintegrating compositions
GB2421431B (en) * 2004-12-24 2007-10-10 Aquasol Ltd Dosing systems
WO2006072878A1 (en) * 2005-01-07 2006-07-13 Ranbaxy Laboratories Limited Oral dosage forms of sertraline having controlled particle size and processes for their preparation
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
US8637080B2 (en) * 2007-06-28 2014-01-28 Osmotica Kereskedelmi és Szolgáltató, KFT Rupturing controlled release device comprising a subcoat
CN105581984A (zh) * 2009-04-09 2016-05-18 阿尔科米斯制药爱尔兰有限公司 药物递送组合物
PT2442791T (pt) 2009-06-16 2020-02-06 Pfizer Formas farmacêuticas de apixaban
IT1399240B1 (it) * 2010-03-22 2013-04-11 Trere Chimica S A S Metodo e prodotto per il trattamento di sostanze alcooliche, mosti d'uva e derivati
CN102379858B (zh) * 2011-10-12 2013-06-19 中国药科大学 一种可装载大剂量难溶性药物并促进其吸收的渗透泵片
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US39691A (en) * 1863-08-25 Improvement in pipe-couplings
US64556A (en) * 1867-05-07 Improved belt-punch
US143272A (en) * 1873-09-30 Improvement in saw-sets
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4036228A (en) * 1975-09-11 1977-07-19 Alza Corporation Osmotic dispenser with gas generating means
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
US4610686A (en) * 1983-11-02 1986-09-09 Alza Corporation Controlled delivery of haloperidol by an osmotic delivery system
US4732915A (en) * 1983-11-02 1988-03-22 Alza Corporation Process for increasing solubility of drug
US4627971A (en) * 1985-04-22 1986-12-09 Alza Corporation Osmotic device with self-sealing passageway
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5071607A (en) * 1990-01-31 1991-12-10 Alza Corporatino Method and apparatus for forming a hole in a drug dispensing device
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5869097A (en) * 1992-11-02 1999-02-09 Alza Corporation Method of therapy comprising an osmotic caplet
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
US5736159A (en) * 1995-04-28 1998-04-07 Andrx Pharmaceuticals, Inc. Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
US6361796B1 (en) * 1996-10-25 2002-03-26 Shire Laboratories, Inc. Soluble form osmotic dose delivery system
AU721653B2 (en) * 1996-10-25 2000-07-13 Supernus Pharmaceuticals, Inc. Soluble form osmotic dose delivery system
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6485748B1 (en) * 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6224907B1 (en) * 1998-03-06 2001-05-01 Alza Corporation Anti-asthma therapy
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6156342A (en) * 1998-05-26 2000-12-05 Andex Pharmaceuticals, Inc. Controlled release oral dosage form
US20010031279A1 (en) * 1998-11-02 2001-10-18 Evangeline Cruz Controlled delivery of antidepressants
JP2000171868A (ja) * 1998-12-08 2000-06-23 Canon Inc フィルム送り装置、フィルム使用装置および光学機器
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
WO2001091716A1 (en) * 2000-05-30 2001-12-06 Add Advanced Drug Delivery Technologies Ag Peroral therapeutic system comprising glipizide
IN190699B (es) * 2001-02-02 2003-08-16 Sun Pharmaceutical Ind Ltd
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin

Also Published As

Publication number Publication date
EP1469826A2 (en) 2004-10-27
ES2277632T3 (es) 2007-07-16
DE60309832T2 (de) 2007-10-11
CA2474425A1 (en) 2003-08-07
KR20040083492A (ko) 2004-10-02
DE60309832D1 (de) 2007-01-04
PL372172A1 (en) 2005-07-11
WO2003063823A2 (en) 2003-08-07
JP2005518418A (ja) 2005-06-23
AR038373A1 (es) 2005-01-12
ATE345776T1 (de) 2006-12-15
NZ533986A (en) 2006-03-31
EP1469826B1 (en) 2006-11-22
ZA200405406B (en) 2005-07-07
NO20043646L (no) 2004-08-31
RU2004123623A (ru) 2005-04-20
PE20030801A1 (es) 2003-09-19
BR0307320A (pt) 2004-12-28
MXPA04007437A (es) 2004-10-11
TW200302748A (en) 2003-08-16
CN1625388A (zh) 2005-06-08
WO2003063823A3 (en) 2003-12-04
UY27644A1 (es) 2003-09-30
PA8565201A1 (es) 2003-12-10
US20030175346A1 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
GT200300017A (es) Sistema de suministro osmotico
PA8493401A1 (es) Uso de inhibidores de cyp2d6 en terapias de combinacion
SV2002000586A (es) Formula de dosificacion de la droga accionada por hidrogel ref. pc11095/700006/b
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
AR058433A1 (es) Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso
HUP0300582A2 (hu) Gyógyszerkészítmények
AR065809A1 (es) Formulaciones farmaceuticas que contienen un inhibidor sglt2
ES2176209T3 (es) Preparacion farmaceutica oral liberable en el tracto digestivo inferior.
ECSP055747A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
UY25055A1 (es) Formulaciones farmacéuticas que contienen voriconazol
UY28040A1 (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos.
CY1108137T1 (el) Συνθεση για εισπνευστηρα δοσομετρημενης δοσης που χρησιμοποιει υδρο-φθορο-αλκανια ως προωθητικα
ECSP077126A (es) Formulaciones en suspensión de aerosol con tg 227 ea o tg 134 a como agentes propulsores
HN2001000006A (es) Antagonistas del factor liberador de corticotropina
AR085778A2 (es) Forma de dosis solida enterica revestida, que comprende acido micofenolico o sal micofenolato
BR0012046A (pt) Composto heterocìclico, composição farmacêutica, inibidor de ativação de ap-1 ou um inibidor da ativação de nf-kappab, inibidor da produção de citocina inflamatória, e, inibidor da produção de metaloprotease de matriz ou inibidor da expressão do fator de adesão de célula inflamatória
DK1796650T3 (da) Transport- og afgivelsesvehikel indeholdende nanopartikler
GB2380675A (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
PA8649901A1 (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
AR025052A1 (es) Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos.
CL2007001752A1 (es) Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral.
CL2012001668A1 (es) Composicion farmaceutica que comprende bromuro de glicopirronio disuelto en un propulsor de hidrofluoroalcano y 5 a 25% de etanol, que contiene de 0,005 y 1 µg/µl de acido clorhidrico 1m; metodo de relleno de un recipiente de aerosol con la composicion farmaceutica; uso en epoc, entre otros.
PE20080400A1 (es) Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas
CL2004000983A1 (es) Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y